Eleven Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 5, 2018-- Eleven Biotherapeutics, Inc. (NASDAQ:EBIO), a late-stage clinical oncology company advancing novel product candidates based on its Targeted Protein Therapeutics (TPTs) platform, today announced that Stephen Hurly, president and chief executive officer, will present a company overview at the Cowen and Company 38th Annual Health Care Conference on Monday, March 12, 2018 at 12:00 p.m. ET in Boston.
For a stock was trading around 9 $ three years ago , we might need to look more deep into this company history . Eleven Biotherapeutics, Inc. is a late-stage, clinical oncology company advancing novel product candidates based upon the Company’s targeted protein therapeutics (TPTs) platform. TPTs incorporate a tumor-targeting antibody fragment and a protein cytotoxic payload into a single protein molecule in order to achieve focused tumor cell killing. Eleven’s lead TPT, Vicinium™, is currently in a Phase 3 trial in non-muscle invasive bladder cancer, with topline three-month data expected in mid-2018. The Company believes its TPT approach offers significant advantages in treating cancer over existing antibody drug conjugate technologies.
So the deal is all about their lead candidate Vicinium the topline three month data expected in mid-2018. We believe this company is trying hard to approve its position on the oncology drugs market. Our rate for this stock is a strong buy for the next 15 days; a good entry could be between 0.89 up to 1.10. The price target for the next 20 days is about 1.50 $.
Important note: We are just a small team of independent traders and uncertified technical chart analysis, and we do not have any insider trading or connection with any company related to any stocks we mentioned. You own your decision to buy, hold or sell any of them.
Pay attention : If you would like to receive our last awesome picks for a day, swing and long trade, please subscribe to our mailing list .
Share on Facebook
Share on Twitter
I'm busy working on my blog posts. Watch this space!